Curaleaf Holdings (CURLF) Liabilities and Shareholders Equity (2019 - 2025)

Curaleaf Holdings (CURLF) recorded quarterly Liabilities and Shareholders Equity of $2.8 billion in Q4 2025, down 3.54% quarter-over-quarter from $2.9 billion in Q4 2024, and down 3.54% on a YoY basis from $2.9 billion in Q4 2024.

Curaleaf Holdings (CURLF) Liabilities and Shareholders Equity (2019 - 2025) Analysis & Trends

Curaleaf Holdings' Liabilities and Shareholders Equity history runs 7 years deep, the most recent figure standing at $2.8 billion for Q4 2025.

  • In Q4 2025, Liabilities and Shareholders Equity fell 3.54% year-over-year to $2.8 billion; the TTM figure through Mar 2026 stood at $2.8 billion (down 68.76% YoY), while the FY2025 annual figure was $2.8 billion, down 3.54% from the prior year.
  • Liabilities and Shareholders Equity was $2.8 billion for Q4 2025 at Curaleaf Holdings, down from $2.9 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $3.5 billion in Q1 2022 to a low of $2.7 billion in Q1 2021.
  • Historically, Liabilities and Shareholders Equity has averaged $3.1 billion across 5 years, with a median of $3.1 billion in 2021.
  • The sharpest annual moves came in 2021 and 2024: Liabilities and Shareholders Equity surged 34.57% in 2021, then decreased 6.67% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $3.1 billion in 2021, then increased by 14.31% to $3.5 billion in 2022, then fell by 12.76% to $3.1 billion in 2023, then decreased by 4.74% to $2.9 billion in 2024, then dropped by 3.54% to $2.8 billion in 2025.
  • The last three Liabilities and Shareholders Equity figures came in at $2.8 billion (Q4 2025), $2.9 billion (Q4 2024), and $3.1 billion (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 40.04 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 15.15 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 6.71 Bn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 555.95 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 4.91 Bn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 13.22 Bn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 4.26 Bn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 2.35 Bn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 2.27 Bn
10 Curaleaf Holdings - - 157.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 2.85 Bn
Dec 31, 2024 2.95 Bn
Sep 30, 2024 3.07 Bn
Jun 30, 2024 3.08 Bn
Dec 31, 2023 3.10 Bn
Sep 30, 2023 3.23 Bn
Jun 30, 2023 3.30 Bn
Mar 31, 2022 3.55 Bn
Dec 31, 2021 3.11 Bn
Sep 30, 2021 3.17 Bn
Jun 30, 2021 3.15 Bn
Mar 31, 2021 2.68 Bn
Dec 31, 2020 2.37 Bn
Sep 30, 2020 2.36 Bn
Dec 31, 2019 736.93 Mn